| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.04T | 1.95T | 1.95T | 1.60T | 1.42T |
| Gross Profit | 207.41B | 209.21B | 211.47B | 154.42B | 150.67B |
| EBITDA | 108.84B | 108.26B | 142.83B | 102.11B | 109.15B |
| Net Income | 23.27B | 16.72B | 57.88B | 14.68B | 39.26B |
Balance Sheet | |||||
| Total Assets | 1.18T | 1.09T | 1.13T | 1.01T | 964.74B |
| Cash, Cash Equivalents and Short-Term Investments | 278.51B | 249.72B | 244.19B | 248.19B | 237.95B |
| Total Debt | 189.34B | 174.05B | 214.78B | 161.98B | 146.92B |
| Total Liabilities | 653.32B | 604.76B | 634.85B | 570.49B | 540.90B |
| Stockholders Equity | 485.26B | 447.42B | 449.60B | 400.74B | 386.16B |
Cash Flow | |||||
| Free Cash Flow | 77.98B | 49.16B | 110.23B | 43.75B | 88.73B |
| Operating Cash Flow | 142.97B | 121.83B | 174.90B | 89.43B | 122.93B |
| Investing Cash Flow | -75.50B | -60.95B | -86.70B | -36.46B | -40.89B |
| Financing Cash Flow | -48.36B | -54.38B | -91.59B | -40.81B | -48.66B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥251.90B | 8.29 | ― | 3.36% | 4.89% | 52.78% | |
76 Outperform | ¥71.41B | 7.00 | 11.87% | 5.00% | -11.12% | 46.62% | |
74 Outperform | ¥538.69B | 8.11 | 8.58% | 2.62% | 8.21% | 72.79% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥398.19B | -20.09 | 3.70% | 3.42% | 4.24% | 39.02% | |
60 Neutral | ¥1.70T | 6.16 | 8.34% | 2.03% | 4.53% | 65.12% | |
58 Neutral | ¥205.39B | 16.01 | ― | 4.77% | -4.64% | -39.59% |